FORBEARANCE AGREEMENTForbearance Agreement • February 8th, 2013 • Transgenomic Inc • Laboratory analytical instruments • Delaware
Contract Type FiledFebruary 8th, 2013 Company Industry JurisdictionThis Forbearance Agreement (this “Agreement”), dated as of February 7, 2013 (the “Agreement Date”), is entered into by and among Transgenomic, Inc., a Delaware corporation (“Borrower”), and Dogwood Pharmaceuticals, Inc. (a wholly owned subsidiary of Forest Laboratories, Inc. (“Forest”) as successor-in-interest to PGxHealth, LLC (“PGX”), (the “Lender”).